GlaxoSmithKline's experimental HIV, A...

GlaxoSmithKline's experimental HIV, AIDS drug to get priority review

There are 2 comments on the San Bernardino County Sun story from Feb 19, 2013, titled GlaxoSmithKline's experimental HIV, AIDS drug to get priority review. In it, San Bernardino County Sun reports that:

U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.

Join the discussion below, or Read more at San Bernardino County Sun.

Anonymous

Baliuag, Philippines

#1 Feb 19, 2013
This is an encouraging news even though nothing is still certain at least there is an action done to find a cure for HIV/AIDS.
Warning FDA Approved

Winnipeg, Canada

#2 Feb 19, 2013
U.S. regulators means FDA. FDA has APPROVED every deadly and damaging Pharma product and its approval means yes Pharma you can use consumers as free test subjects for poorly tested , faulty, fraudulent product.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Ring-ring: Cellphone interrupts Supreme Court h... Apr 25 better call Saul 1
News Mumps outbreak probably isn't related to vaccin... Apr 18 MMR 1
News Bristol Palin says abstinence best path for teens (May '09) Apr 3 Coonway Tweety 2,658
News After Trump rally, equity investors move into h... Mar '17 Retribution 6
News N/R: Lack of mental, epileptic drugs hit health... Mar '17 Humanspirit 1
News The EpiPen debacle may be the shot heard around... Feb '17 Suezanne 2
News Despite $19 million salary, Mylan CEO failed to... (Sep '16) Feb '17 Suezanne 3
More from around the web